GSK4527363
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4527363, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants [Phase 1]